Department Introduction Department Overview The Department of Gastroenterology at Ruijin Hospital has a history of 70 years. In 1980, it was approved by the National Education Commission and the Academic Degrees Committee of the State Council as a master's degree program, in 1984 as a doctoral degree program, and in 2000 as a postdoctoral research station. In 1990, it was approved as one of the constituent units of the National Ministry of Education Key Discipline in Gastroenterology. In 1997, it became a constituent unit of the National 211 Project Key Discipline in Gastroenterology at Shanghai Jiao Tong University School of Medicine, and in the same year was approved by the National Ministry of Health as a National Drug Clinical Research Base. In 2010, it was selected as a National Clinical Key Specialty by the National Health and Family Planning Commission. Multiple key personnel serve in healthcare work for the Central Health Committee. The Department of Gastroenterology at Ruijin Hospital comprises the gastroenterology outpatient clinic, gastroenterology wards, digestive endoscopy center, gastrointestinal motility research laboratory, and digestive laboratory. The total area is 5,003 m2, with 72 open beds. Each year, the outpatient clinic treats approximately 166,000 patient visits, with 5,154 admissions and discharges, and over 70,000 endoscopic examinations and treatments. The Department of Gastroenterology at Ruijin Hospital has a group of highly respected, erudite, and internationally renowned senior experts, such as: Xu Jiayu, Tang Zhenduo, Wu Yuxin, Wang Guanting, Jiang Shihu, Wu Yunlin, Yuan Yaozong, and others, who have made tremendous contributions to the development of gastroenterology. The department has obtained 51 national-level research projects, with total research funding reaching 26.03 million yuan. It has repeatedly received the National Science and Technology Progress Second Prize, Shanghai Science and Technology Progress Second Prize, and Shanghai Medical Third Prize. A total of over 248 SCI papers have been published, with the highest impact factor reaching 66.85 and a total impact factor of 3,556. Currently, the core leadership team composed of Zou Duowu, Zhong Jie, Wang Lifu, and Sun Yunwei is leading the Ruijin Department of Gastroenterology toward higher goals. The Department of Gastroenterology team at Ruijin Hospital currently has 42 physicians and 1 researcher. 71% of physicians hold doctoral or master's degrees. Among them, there are 7 with senior professional titles, 14 with associate senior professional titles, and 17 with intermediate professional titles. 45% of gastroenterology physicians have overseas study experience in the United States, France, Australia, Japan, and other countries. Currently, the department maintains [text incomplete in original] with countries such as the United States, France, and Australia, as well as the Hong Kong region. The specialty characteristics of the Department of Gastroenterology at Ruijin Hospital are mainly in the following six aspects: (1) inflammatory bowel disease; (2) early gastrointestinal cancer; (3) digestive endoscopy; (4) pancreatic diseases; (5) gastrointestinal motility disorders; (6) difficult and complex digestive diseases. In the Shanghai Shenkang disease category statistics ranking, the Department of Gastroenterology at Ruijin Hospital ranks 2nd citywide in inflammatory bowel disease, pancreatic tumors, and complex ERCP, and 6th citywide in gastrointestinal bleeding. Based on its comprehensive strength, the Department of Gastroenterology at Ruijin Hospital courageously accepts and diagnoses various difficult and complex diseases, and has extensive experience in the diagnosis and treatment of difficult and complex diseases. Each year, it receives a large number of patients with difficult and complex diseases from all over the country, such as: T-cell lymphoma, eosinophilic gastroenteritis, blue rubber bleb nevus syndrome, pancreaticobiliary maljunction, pancreas divisum, autoimmune pancreatitis, protein-losing enteropathy, Behçet's encephalopathy, Cronkhite-Canada syndrome, tumefactive lipomatosis syndrome, phlebosclerotic colitis, cloaca, gastrointestinal amyloidosis, and other difficult and complex diseases.